Cover Image

Protocol for a pragmatic trial of Cannabidiol (CBD) to improve chronic pain symptoms among United States Veterans

Abstract Background Chronic pain affects over 100 million Americans, with a disproportionately high number being Veterans. Chronic pain is often difficult to treat and responds variably to medications, with many providing minimal relief or having adverse side effects that preclude use. Cannabidiol (...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rachel S. Bergmans (Author), Riley Wegryn-Jones (Author), Catherine Klida (Author), Vivian Kurtz (Author), Laura Thomas (Author), David A. Williams (Author), Daniel J. Clauw (Author), Kelley M. Kidwell (Author), Amy S. B. Bohnert (Author), Kevin F. Boehnke (Author)
Format:	Book
Published:	BMC, 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis
by: Christopher J Failing, et al.
Published: (2021)

The use of cannabidiol (CBD) as an analgesic component
by: Kristian Kjær-Staal Petersen, et al.
Published: (2023)

Towards Better Delivery of Cannabidiol (CBD)
by: Sophie Anne Millar, et al.
Published: (2020)

The Anti-Inflammatory Effects of Cannabidiol (CBD) on Acne
by: Peyravian N, et al.
Published: (2022)

Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders
by: Baswan SM, et al.
Published: (2020)

Impact of smoking cannabidiol (CBD)-rich marijuana on driving ability
by: Tim J. Gelmi, et al.
Published: (2021)

Total cannabidiol (CBD) concentrations and yields from traditional extraction methods: Percolation vs. maceration
by: Jason Wilson, et al.
Published: (2022)

Current state of knowledge on the use of cannabidiol (CBD) in various medical conditions
by: Zuzanna Lubczyńska, et al.
Published: (2023)

Cannabidiol in sports: insights on how CBD could improve performance and recovery
by: Daniel Rojas-Valverde, et al.
Published: (2023)

Cannabidiol (CBD) Supports the Honeybee Worker Organism by Activating the Antioxidant System
by: Patrycja Skowronek, et al.
Published: (2023)

Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer
by: Uchini S. Kosgodage, et al.
Published: (2018)

Cannabidiol (CBD): A Systematic Review of Clinical and Preclinical Evidence in the Treatment of Pain
by: Guillermo Cásedas, et al.
Published: (2024)

Cannabidiol (CBD) Alters the Functionality of Neutrophils (PMN). Implications in the Refractory Epilepsy Treatment
by: Claudia Taborda Gómez, et al.
Published: (2021)

Label accuracy of unregulated cannabidiol (CBD) products: measured concentration vs. label claim
by: Erin Johnson, et al.
Published: (2022)

Mucoadhesion and Mucopenetration of Cannabidiol (CBD)-Loaded Mesoporous Carrier Systems for Buccal Drug Delivery
by: Ulrike Söpper, et al.
Published: (2021)

Staff awareness of the use of cannabidiol (CBD): a trust-wide survey study in the UK
by: Obioha Ukaegbu, et al.
Published: (2021)

Primary care provider attitudes, experiences and practices about cannabidiol (CBD) and barriers to patient-provider communication about CBD use: A qualitative study
by: Pravesh Sharma, et al.
Published: (2022)

Bioactive Properties and In Vitro Digestive Release of Cannabidiol (CBD) from Tailored Composites Based on Carbon Materials
by: Karol Zapata, et al.
Published: (2024)

Attitudes, beliefs, and changing trends of cannabidiol (CBD) oil use among caregivers of individuals with Alzheimer's disease
by: Magdalena Leszko, et al.
Published: (2021)

Stable Isotope Ratio Analysis for Authentication of Natural Antioxidant Cannabidiol (CBD) from <i>Cannabis sativa</i>
by: Matteo Perini, et al.
Published: (2023)

UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations
by: Sara Malaca, et al.
Published: (2021)

A comparison of advertised versus actual cannabidiol (CBD) content of oils, aqueous tinctures, e-liquids and drinks purchased in the UK
by: Drusus A. Johnson, et al.
Published: (2023)

Regulatory Effect of Cannabidiol (CBD) on Decreased β-Catenin Expression in Alopecia Models by Testosterone and PMA Treatment in Dermal Papilla Cells
by: Yoon-Jong Park, et al.
Published: (2021)

Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems
by: Julie Moltke, et al.
Published: (2021)

Effect of aerosolized nicotine on human bronchial epithelial cells is amplified after co-administration with cannabidiol (CBD): a pilot in vitro study
by: Noel J. Leigh, et al.
Published: (2020)

CBD What Does the Science Say?
by: Parker, Linda A.
Published: (2022)

Study of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) extraction FROM dried oral fluid spots (DOFS) and LC-MS/MS detection
by: Roberta Gorziza, et al.
Published: (2021)

Fabrication and Preliminary In Vitro Evaluation of 3D-Printed Alginate Films with Cannabidiol (CBD) and Cannabigerol (CBG) Nanoparticles for Potential Wound-Healing Applications
by: Paraskevi Kyriaki Monou, et al.
Published: (2022)

Effect of a Δ9-tetrahydrocannabinol (THC)/cannabidiol (CBD) formulation on cell monolayer viability and mitochondria integrity: Significance of the drug carrier/delivery system
by: Steven M Lipson, et al.
Published: (2020)

Oral cannabidiol (CBD) as add-on to paracetamol for painful chronic osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trialResearch in context
by: Sibylle Pramhas, et al.
Published: (2023)

Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report
by: Noa Raz, et al.
Published: (2022)

Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot
by: Sarah D. Pennypacker, et al.
Published: (2022)

High-CBD Extract (CBD-X) in Asthma Management: Reducing Th2-Driven Cytokine Secretion and Neutrophil/Eosinophil Activity
by: Miran Aswad, et al.
Published: (2024)

Diversity of molecular targets and signaling pathways for CBD
by: Douglas L. deAlmeida, et al.
Published: (2020)

Healthcare provider and medical cannabis patient communication regarding referral and medication substitution: the Canadian context
by: Alexis Holman, et al.
Published: (2022)

Clinical and Family Implications of Cannabidiol (CBD)-Dominant Full-Spectrum Phytocannabinoid Extract in Children and Adolescents with Moderate to Severe Non-Syndromic Autism Spectrum Disorder (ASD): An Observational Study on Neurobehavioral Management
by: Jeanne Alves de Souza Mazza, et al.
Published: (2024)

A randomized, double-blind, placebo-controlled, repeated-dose pilot study of the safety, tolerability, and preliminary effects of a cannabidiol (CBD)- and cannabigerol (CBG)-based beverage powder to support recovery from delayed onset muscle soreness (DOMS)
by: Erica N. Peters, et al.
Published: (2023)

Acute effects of naturalistic THC vs. CBD use on recognition memory: a preliminary study
by: Tim Curran, et al.
Published: (2020)

CBD and THC in Special Populations: Pharmacokinetics and Drug-Drug Interactions
by: Lixuan Qian, et al.
Published: (2024)

An Intravenous Pharmacokinetic Study of Cannabidiol Solutions in Piglets through the Application of a Validated Ultra-High-Pressure Liquid Chromatography Coupled to Tandem Mass Spectrometry Method for the Simultaneous Quantification of CBD and Its Carboxylated Metabolite in Plasma
by: Nathan Koch, et al.
Published: (2024)